CalciMedica (CALC) Other Non-Current Assets (2019 - 2026)
CalciMedica's (CALC) quarterly Other Non-Current Assets came in at $11000.0 in Q1 2026, little changed YoY from $11000.0 in Q1 2025, and little changed on a QoQ basis from $11000.0 in Q4 2025.
CalciMedica (CALC) Other Non-Current Assets (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Other Non-Current Assets data on file, last reported at $11000.0 in Q1 2026.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $11000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $11000.0, up 10.0% from the prior year.
- Other Non-Current Assets steadied at $11000.0 in Q1 2026, from $11000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.4 million in Q4 2022 to a low of $1000.0 in Q2 2023.
- A 5-year average of $239266.7 and a median of $27000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 47100.0% — and 2025, when it plunged 97.67%.
- Tracing CALC's Other Non-Current Assets over 5 years: stood at $1.4 million in 2022, then tumbled by 71.0% to $413000.0 in 2023, then slumped by 97.58% to $10000.0 in 2024, then climbed by 10.0% to $11000.0 in 2025, then changed by 0.0% to $11000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $11000.0 (Q1 2026), $11000.0 (Q4 2025), and $11000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 62.96 Mn |
| 10 | CalciMedica | 9.71 Mn | -8.91 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 396,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 377,000.00 |
| Dec 31, 2023 | 413,000.00 |
| Sep 30, 2023 | 385,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Dec 31, 2022 | 1.42 Mn |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 29,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 136,000.00 |
| Mar 31, 2021 | 29,000.00 |